Cava's CEO said weight-loss drugs are fuelling the rise of a "big kids" market. Dixie D. Vereen/For The Washington Post via Getty ImagesDiners on GLP-1 drugs are increasingly opting for kids' meals, said Cava CEO Brett Schulman. He called this group of consumers "big kids." GLP-1 drugs…This story appeared on businessinsider.com , 2026-08-12 05:59:39.